COMMUNIQUÉS West-GlobeNewswire

iKang Enters into Amendment to Merger Agreement for Going Private Transaction
29/05/2018
BEIJING, May 29, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Avid Bioservices to Participate at BIO International Convention 2018
29/05/2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- -- Company’s Newly Appointed [...]
Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse® (Amifampridine Phosphate) for Lambert-Eaton Myasthenic Syndrome
29/05/2018
--PDUFA Date Set for November 28, 2018 CORAL GABLES, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and [...]
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29/05/2018
Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
29/05/2018
WALTHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that management will participate in the Jefferies 2018 Healthcare Conference on Tuesday, June 5 th at 3:30 p.m [...]
Abiomed to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
DANVERS, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]
Albireo to Present at Jefferies 2018 Global Healthcare Conference
29/05/2018
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress
29/05/2018
RESEARCH TRIANGLE PARK, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]
CASMED to Present at the 8th Annual LD Micro Invitational Conference on June 5
29/05/2018
BRANFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief [...]
SCOUTCare™ Honored with Prestigious Aster Awards for Healthcare Communications
29/05/2018
Cianna Medical Continues to Expand Use of Innovative SAVI SCOUT® Technology and Supports Hospitals’ Mission to Become Wire-free Providers ALISO VIEJO, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the [...]
UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a [...]
FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries
29/05/2018
YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
29/05/2018
AUSTIN, Texas, May 29, 2018 (GLOBE NEWSWIRE) -- Savara, Inc. (NASDAQ: SVRA ), an orphan lung disease company, today provided an update on two case reports exploring the use of aerosolized granulocyte-macrophage colony [...]
Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
29/05/2018
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]
Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting
29/05/2018
Company’s Chief Scientific Officer, Phil Skolnick, Ph.D., to Receive ASCP’s “Donald Klein Lifetime Achievement Award” SANTA MONICA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") ( [...]
Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update
29/05/2018
Commences commercial production at its Pure Sunfarms Delta 3 joint venture greenhouse operation VICTORIA, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF [...]
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy
29/05/2018
TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
PolarityTE to host Key Opinion Leader Summit
29/05/2018
SALT LAKE CITY, May 29, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (Nasdaq: COOL ) today announced it will host a breakfast event in New York City with key opinion leaders (KOLs) to highlight the current treatment [...]
Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA
29/05/2018
NORTHVALE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc (OTCBB: ELTP ) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, Inc., USA to [...]

Pages